Omron's profit drivers are its industrial automation and healthcare businesses, with the firm as one of the leading domestic players in the factory automation control equipment market. The industrial automation segment is well positioned for secular growth, driven by aging populations in developed markets, increasing labor costs, and production safety demands. OMRON outlined a five-year roadmap (2026–2030) focused on growth through investment, structural reform, and digital transformation, with 13 focus businesses identified as growth drivers.
Cyborg Score Rationale
H1 FY2025 net sales rose 5.0% year-over-year with net income at JPY9.0 billion, a turnaround from a prior-year loss, though profits declined due to lower gross margins. Omron is undervalued by 31%, presenting a strong buy opportunity due to excessive market pessimism and resilient fundamentals in automation and healthcare. Strong market position tempered by near-term margin pressures.
Top Insights
IAB segment achieved higher revenue and profit, supported by semiconductor and battery demand, while HCB lagged due to weak China consumption.
13 focus businesses account for 50% of revenue and 80% of profit; capital allocation plan of JPY1.05 trillion over five years, with 80% for business investment.
Aims for above-market growth in focus businesses with a CAGR of 6% for IAB segment; plans to expand customer base from 20,000 to 110,000 through distributor collaboration.
Omron aims to improve gross profit margin by 2.5 percentage points by 2030 through substantial investments in business development and innovation while optimizing supply chain in China.
Named Competitors
SIMATIC — Industrial automation control systems and PLCs
ABB Robotics — Factory automation and industrial robotics solutions
MELSEC — Programmable logic controllers and factory automation
Philips Healthcare — Medical devices and healthcare solutions
Recent Developments
(Feb 2026) Strong technical buy signal with stock trading at 4,532 JPY, up significantly from 52-week lows
(Nov 2025) Full-year FY2025 forecasts revised upward with expectations for higher revenue and profit
(Nov 2025) H1 FY2025 net sales rose 5.0% YoY to JPY393.4 billion with profit turnaround
Open the full interactive OMRON Corporation report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.